Novo Pharm Formulations Private Limited, a active private limited company, was established on 20 March 1995 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24231GJ1995PTC025060. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Ojasbhai Ravjibhai Patel (Director), Jaikrishan Dwarikanath Kotru (Director), Dhwani Ojas Patel (Director). It holds ₹1.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 105 Rajmandir Appartment, 62, Alkapuri Society, R.C. Dutt Road, Alkapuri,, Vadodara, Gujarat, 390007.
U24231GJ1995PTC025060
025060
20 March 1995
₹0.20 M
₹0.15 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Novo Pharm Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ojasbhai Ravjibhai Patel | Director | 25 Oct 1999 | Current |
| Jaikrishan Dwarikanath Kotru | Director | 27 Mar 2015 | Current |
| Dhwani Ojas Patel | Director | 13 Dec 2021 | Current |
| Ravjibhai Ashabhai Patel | Director | 09 Apr 2007 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novo Pharm Formulations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 34.61% increase. The company also saw a substantial improvement in profitability, with a 36.68% increase in profit. The company's net worth Soared by an impressive increase of 14.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Novo Pharm Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Dec 2011 | The Baroda City Co - Operative Bank Limited | ₹0.40 M | Open |
| 26 Dec 2011 | The Baroda City Co - Operative Bank Limited | ₹0.60 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Novo Pharm Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Novo Pharm Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novo Pharm Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Novo Pharm Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Novo Pharm Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity Dhwani Ojas Patel was appointed as a Director was appointed as a Director on 13 Dec 2021 & has been associated with this company since 3 years 11 months . was completed.
The activity Jaikrishan Dwarikanath Kotru was appointed as a Director was appointed as a Director on 27 Mar 2015 & has been associated with this company since 10 years 8 months . was completed.
The activity A charge with The Baroda City Co - Operative Bank Limited amounted to Rs. 0.40 M with Charge ID 10327943 was registered on 29 Dec 2011. was completed.
Progress on A charge with The Baroda City Co - Operative Bank Limited amounted to Rs. 0.60 M with Charge ID 10327945 was registered on 26 Dec 2011. was documented.
The CIN of Novo Pharm Formulations Private Limited is U24231GJ1995PTC025060.
Novo Pharm Formulations Private Limited is headquartered at 105 Rajmandir Appartment, 62, Alkapuri Society, R.C. Dutt Road, Alkapuri,, Vadodara, Gujarat, 390007.
Novo Pharm Formulations Private Limited was incorporated on 20 March 1995.
The current directors of Novo Pharm Formulations Private Limited are
The primary industry of Novo Pharm Formulations Private Limited is Trade.
Novo Pharm Formulations Private Limited is unlisted.
The authorized capital of Novo Pharm Formulations Private Limited is ₹0.20 M, and the paid-up capital is ₹0.15 M.
The compliance status of Novo Pharm Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX